Correction: Glioblastoma and glioblastoma stem cells are dependent on functional MTH1

Linda Pudelko; Pegah Rouhi; Kumar Sanjiv; Helge Gad; Christina Kalderén; Andreas Höglund; Massimo Squatrito; Alberto J. Schuhmacher; Steven Edwards; Daniel Hägerstrand; Ulrika Warpman Berglund; Thomas Helleday; Lars Bräutigam

doi:10.18632/oncotarget.27484

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Glioblastoma and glioblastoma stem cells are dependent on functional MTH1

PDF | How to cite

Oncotarget. 2020; 11:827-827. https://doi.org/10.18632/oncotarget.27484

Metrics: PDF 1769 views | ?

Linda Pudelko¹, Pegah Rouhi^1,5, Kumar Sanjiv¹, Helge Gad¹, Christina Kalderén¹, Andreas Höglund¹, Massimo Squatrito², Alberto J. Schuhmacher², Steven Edwards³, Daniel Hägerstrand⁴, Ulrika Warpman Berglund¹, Thomas Helleday¹ and Lars Bräutigam¹

¹ Department of Medical Biochemistry and Biophysics, Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Karolinska Institutet, Stockholm, Sweden
² Cancer Cell Biology Programme, Seve Ballesteros Foundation Brain Tumor Group, Centro Nacional de Investigaciones Oncológicas, CNIO, Madrid, Spain
³ Department of Applied Physics, Science for Life Laboratory, Royal Institute of Technology, Stockholm, Sweden
⁴ Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
⁵ Department of Oncology, Lab of Tumor Inflammation and Angiogenesis, KU Leuven, Leuven, Belgium

Published: February 25, 2020

This article has been corrected: The Funding information has been updated. The complete Funding list is shown below:

FUNDING

This work was supported by the Karolinska Institutes KID funding (LP), the Seve Ballesteros Foundation to MS, the Marie Curie foundation (CIG-618751 MS), the Knut and Alice Wallenberg Foundation (KAW2014.273 TH), the Swedish Foundation for Strategic Research (RB13-0224 TH), the Swedish Cancer Society (TH), the Swedish Research Council (2015-00162 TH), the Göran Gustafsson Foundation (TH), the Swedish Children’s Cancer Foundation (to TH), the Swedish Pain Relief Foundation (PR20140048 TH), the Torsten and Ragnar Söderberg Foundation (TH), and the European Research Council (TAROX-695376).

Original article: Oncotarget. 2017; 8:84671–84684. DOI: https://doi.org/10.18632/oncotarget.19404.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 27484

Publication Alerts

Post-Publication Promotion

Publication Discount

Corrections:

Correction: Glioblastoma and glioblastoma stem cells are dependent on functional MTH1